HOFSETH BIOCARE ASA: PRIVATE PLACEMENT SUCCESSFULLY PLACED

About this update from Hofseth Biocare Asa

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANOTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement from Hofseth BioCare ASA ("HBC" or the "Company") published on 26 June 2026 regarding a private placement (the "Private Placement") of between 96,153,846 and 134,615,384 new shares ("Offer Shares") at a fixed price per share of NOK 1.30 (the "Offer Price") corresponding to a total Private Placement size of between approximately NOK 125 million and NOK 175 million (the "Offer Size"). The Company is pleased to announce that the Board of Directors has now allotted 111,154,608 Offer Shares at the Offer Price, corresponding to gross proceeds of approximately NOK 144.5 million. The Offer Shares will be settled with a combination of cash and conversion of receivables towards the Company, of which Offer Shares for an amount of approximately NOK 66.5 million will be settled through conversion of receivables towards the Company. The net proceeds of the Private Placement will be used for growth capital, strengthening of the balance sheet and for general corporate purposes. The following investors pre-committed to subscribe for Offer Shares and have been allocated Offer Shares in the Private Placement as set out below:

View stock analysis, news, and events for Hofseth Biocare Asa